Cycle Pharmaceuticals announced the launch of HARLIKU, the first and only FDA-approved treatment for reducing urinary homogentisic acid (HGA) in adult patients with alkaptonuria (AKU). 1 AKU, also ...

Looking for the best tablet of 2025? Whether you need to know the best tablet to buy as a powerful device for work, a budget-friendly option for casual use, or something in between, we’ve tested ...

Lumefantrine (LMF) and artemether (ART) are antimalarial agents used in artemisinin-based combination therapy (ACT), which is recommended as a fixed-dose oral combination for the treatment of ...

New Delhi: The Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central Drugs Standard Control Organization (CDSCO) has recommended market approval for ...